- $0.03m
- $1.25bn
- $2.79bn
Annual income statement for ModivCare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,369 | 1,997 | 2,504 | 2,751 | 2,788 |
| Cost of Revenue | |||||
| Gross Profit | 290 | 426 | 486 | 460 | 433 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,247 | 1,908 | 2,447 | 2,891 | 2,892 |
| Operating Profit | 122 | 89.4 | 57.1 | -140 | -105 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 104 | 40.3 | -4.88 | -209 | -199 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 82.4 | 31.7 | -1.84 | -205 | -193 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 88.8 | -6.58 | -31.8 | -204 | -201 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 32.5 | -6.58 | -31.8 | -204 | -201 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.37 | -0.773 | -2.6 | -6.26 | -8.79 |